Showing 2,501 - 2,520 results of 3,189 for search '"vaccination"', query time: 0.07s Refine Results
  1. 2501

    Chaotic and Quasi-periodic Regimes in the Covid-19 Mortality Data by Ekrem Aydıner, Erkan Yılmaz

    Published 2024-03-01
    “…It is accepted that even if there are vaccines developed against the virus, it will never be possible to predict very complex spread dynamics and reach a spread pattern due to new variants and other parameters. …”
    Get full text
    Article
  2. 2502

    Canine adenovirus serotype 2 isolation and determination of its cultivation parameters by A. A. Klimova

    Published 2024-12-01
    “…Primarily, the virus strains currently important and circulating in the particular territory shall be used for vaccine production to induce long-term and strong immunity in animals. …”
    Get full text
    Article
  3. 2503

    Study of cultural properties of canine enteric coronavirus isolate in different cell cultures by A. A. Komarova, T. S. Galkina

    Published 2023-03-01
    “…In this regard, the prevention of this disease is still an acute problem; firstly this means the development of effective vaccines, which can provide are liable protection from the infection. …”
    Get full text
    Article
  4. 2504

    Rabies Elimination: Is It Feasible without Considering Wildlife? by Krishna Prasad Acharya, Rakesh Chand, Falk Huettmann, Tirth Raj Ghimire

    Published 2022-01-01
    “…Rabies is a vaccine-preventable fatal viral disease that is zoonotic in nature. …”
    Get full text
    Article
  5. 2505
  6. 2506

    Tracking acute flaccid paralysis in Niger: a half-decade epidemiological portrait (2016–2021) by El Khalef Ishagh, Marc Talatou Ouédraogo, Batouré Oumarou, Mutenda Sheria Kaya, Gbaguidi Aichatou Diawara, Abdoulaye Macire Camara, Seyni Moussa, Kuyangisa Bienvenu, Joseph Toko, Hamidou Harouna, Haladou Moussa, N.’Zue Kofi, Jacques L. Tamuzi, Patrick D. M. C. Katoto, Charles S. Wiysonge, Blanche-Philomene Melanga Anya, Manengu Casimir Tshikolasoni

    Published 2025-01-01
    “…Abstract Background Recently, a total of 74 circulating vaccine-derived poliovirus (cVDPV) outbreaks were detected in 39 countries, with 672 confirmed Acute Flaccid Paralysis (AFP) cases identified in 27 countries. …”
    Get full text
    Article
  7. 2507

    Effective Binding of a Phosphatidylserine-Targeting Antibody to Ebola Virus Infected Cells and Purified Virions by S. D. Dowall, V. A. Graham, K. Corbin-Lickfett, C. Empig, K. Schlunegger, C. B. Bruce, L. Easterbrook, R. Hewson

    Published 2015-01-01
    “…Currently, no antiviral or vaccine is licensed against Ebola virus. A phosphatidylserine-targeting antibody (PGN401, bavituximab) has previously been shown to have broad-spectrum antiviral activity. …”
    Get full text
    Article
  8. 2508

    Induction of Humoral and Cellular Immunity by Intradermal Delivery of SARS-CoV-2 Nucleocapsid Protein Using Dissolvable Microneedles by Chaiyaporn Kuwentrai, Jinming Yu, Bao-zhong Zhang, Ye-fan Hu, Ying Dou, Hua-rui Gong, Jian-Dong Huang, Chenjie Xu

    Published 2021-01-01
    “…This makes the nucleocapsid protein a suitable candidate for developing a vaccine against SARS-CoV-2 infection. This article reports the intradermal delivery of NP antigen using dissolvable microneedle skin patches that could induce both significant B cell and T cell responses.…”
    Get full text
    Article
  9. 2509

    Novel Generalized Divergence Measure on Intuitionistic Fuzzy Sets and Its Application by Priya Arora, V. P. Tomar

    Published 2021-01-01
    “…There are some diseases for which vaccine is not available. In that case, we have devised a method to choose the best treatment for the patients based on the results of clinical trials.…”
    Get full text
    Article
  10. 2510
  11. 2511

    Tetanus Toxoid Immunization Status and Associated Factors among Mothers in Damboya Woreda, Kembata Tembaro Zone, SNNP, Ethiopia by Muluken Dubale Mamoro, Lolemo Kelbiso Hanfore

    Published 2018-01-01
    “…Even though most mothers had access for TT immunization service, they were not immunized with protective doses of TT vaccine.…”
    Get full text
    Article
  12. 2512
  13. 2513

    Life Science 2.0: reframing the life science sector for ‘the benefit on mankind’ by Michaela Vallin, Göran Tomson, Beate Kampmann, Eivind Engebretsen, Stefan Swartling Peterson, Rhoda K. Wanyenze, Ole Petter Ottersen

    Published 2024-12-01
    “…The COVID-19 pandemic put the life science sector to the test. Vaccines were developed at unprecedented speed, benefiting from decades of fundamental research and now honoured by a Nobel Prize. …”
    Get full text
    Article
  14. 2514

    Expression of Helicobacter pylori hspA Gene in Lactococcus lactis NICE System and Experimental Study on Its Immunoreactivity by Xiao-Juan Zhang, Shu-Ying Feng, Zhi-Tao Li, Yan-Ming Feng

    Published 2015-01-01
    “…The aim of this study was to develop an oral Lactococcus lactis (L. lactis) vaccine against Helicobacter pylori (H. pylori). Methods. …”
    Get full text
    Article
  15. 2515

    Multiplayer games and HIV transmission via casual encounters by Stephen Tully, Monica-Gabriela Cojocaru, Chris T. Bauch

    Published 2017-03-01
    “…We study the sensitivity of Nash strategies with respect to varying preference rankings, and the impact of a prophylactic vaccine introduced in players of youngest age groups. …”
    Get full text
    Article
  16. 2516

    Leveraging Quantum LSTM for High-Accuracy Prediction of Viral Mutations by Prashanth Choppara, Bommareddy Lokesh

    Published 2025-01-01
    “…The rapid mutations of viruses such as COVID-19 pose significant challenges for vaccine development and effective disease management. …”
    Get full text
    Article
  17. 2517

    Nasopharyngeal carriage of Streptococcus pneumoniae in Latin America and the Caribbean: A systematic review and meta-analysis. by Martín Brizuela, María Carolina Palermo, Tomás Alconada, María Macarena Sandoval, Eugenia Ramirez Wierzbicki, Joaquín Cantos, Paula Gagetti, Agustín Ciapponi, Ariel Bardach, Silvina Ruvinsky

    Published 2024-01-01
    “…<h4>Objectives</h4>To estimate the pneumococcal nasopharyngeal burden in all age groups in Latin America and the Caribbean (LAC) before, during, and after the introduction of pneumococcal vaccine conjugate (PVC).<h4>Methods</h4>Systematic literature review of international, regional, and country-published and unpublished data, together with reports including data from serotype distribution in nasopharyngeal carriage in children and adults from LAC countries following Cochrane methods. …”
    Get full text
    Article
  18. 2518

    Development and characterization of a reverse genetics system for the lineage II Chicava strain of Machupo virus in a guinea pig model. by Emily Mantlo, Junki Maruyama, John T Manning, Rachel A Reyna, Cheng Huang, Slobodan Paessler

    Published 2025-01-01
    “…<h4>Background</h4>Machupo virus (MACV) is a New World mammarenavirus (hereafter referred to as "arenavirus") and the etiologic agent of Bolivian hemorrhagic fever (BHF). No vaccine or antiviral therapy exists for BHF, which causes up to 35% mortality in humans. …”
    Get full text
    Article
  19. 2519
  20. 2520